Publications citing Assaypro: Human PAI-1 ELISA Kit ... (175 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.Sputum plasminogen activator inhibitor-1 elevation by oxidative stress-dependent nuclear factor-?B activation in COPD
Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors
Pleural Effusion and Plasma Levels of Fibrinolytic Parameters in Tuberculosis Pleurisy and Contribution to the Diagnosis.
Coagulation, fibrinolysis and inhibitors in failing filters during continuous venovenous hemofiltration in critically Ill patients with acute kidney injury: effect of
- https://karger.com/bpu/article/39/4/297/48520
- L Schilder, SA Nurmohamed, PM ter Wee - Blood , 2015 - karger.com
- Introduction: The mechanisms of early filter failure and clotting with different anticoagulation modalities during continuous venovenous hemofiltration (CVVH) are largely unknown.
Tberkloz Plrezide Fibrinolitik Parametrelerin Plevra S?v?s?, Plazmadaki Dzeyleri ve Tan?ya Katk?s?
Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed
Regular resistance training enhances fibrinolytic potential but does not affect coagulation
Comparison of the effects of intensive insulin treatment modalities on cardiovascular biomarkers in type 1 diabetes mellitus
Plasma Levels of Plasminogen Activator Inhibitor Type 1 and Vitronectin in Children With Cancer
- https://journals.sagepub.com/doi/abs/10.1177/1076029614531450
- D Tugcu, O Devecioglu, A Unuvar - Clinical and Applied , 2016 - journals.sagepub.com
- Background: The plasminogen activator system controls intravascular fibrin deposition; besides, it also participates in a wide variety of physiologic and pathologic processes, including
Comparison of the effects of intensive insulin treatment
Evaluation of thrombomodulin/thrombin activatable fibrinolysis inhibitor function in plasma using tissue-type plasminogen activator-induced plasma clot lysis
- https://www.sciencedirect.com/science/article/pii/S2475037924001523
- T Urano, Y Sano, Y Suzuki, M Okada, H Sano - Research and Practice , 2024 - Elsevier
- Background Thrombin activatable fibrinolysis inhibitor (TAFI) is one of the most important physiological fibrinolysis inhibitors. Its inhibitory efficacy under physiological conditions
AMP-activated protein kinase, Sirtuin 1, and p53 interactions in HEPG2 cells
?nflamatuar barsak hastal???nda erken aterosklerozun de?erlendirilmesi
Evaluating the effect of antidiabetic treatment on haemostatic and fibrinolytic parameters among type 2 diabetics in Ilorin, Nigeria
Drospirenone effects on the plasminogen activator system in immortalized human endometrial endothelial cells
Arsenite Inhibits Tissue-Type Plasminogen Activator Synthesis through NRF2 Activation in Cultured Human Vascular Endothelial EA.hy926 Cells
Regular Resistance Training Enhances Fibrinolytic Potential but Does Not Affect Coagulation
Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina
Cadmium induces plasminogen activator inhibitor-1 via Smad2/3 signaling pathway in human endothelial EA. hy926 cells
Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease
Nobiletin represses change in the levels of blood coagulation markers in the LPS-induced rat DIC model
Hemostatic Adaptations to High Intensity Interval Training in Healthy Adult Men
Endothelial dysfunction in children with frequently relapsing and steroid-resistant nephrotic syndrome
Acute fbrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study
Relationship among HbA1c and Some Markers of Endothelial Damage in Type 2 Diabetes Mellitus
Homocysteine-Enhanced Proteolytic and Fibrinolytic Processes in Thin Intraluminal Thrombus and Adjacent Wall of Abdominal Aortic Aneurysm: Study In Vitro
Can biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies?
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystic ovary syndrome: A random?zed controlled study
Establishment of disseminated intravascular coagulation (DIC) modelby a single iv administration of Escherichia coli-derived lipopolysaccharide (LPS) to cynomolgus monkeys and evaluation of itspathophysiological status
Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries
Intervention of chlorogenic acid, caffeic acid and ferulic acid on the expression of inflammation-related molecules in endothelial cells caused by complement bypass activation
Frailty has a stronger association with inflammation than age in older veterans
Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy
A microfluidic cell culture system for monitoring of sequential changes in endothelial cells after heat stress
Coagulation, fibrinolysis and inhibitors in failing filters during continuous venovenous haemofiltration in critically ill patients with acute kidney injury: effect of anticoagulation modalities
Effects of Selenium Supplementation on Soluble FMS-Like Tyrosine Kinase-1 and Glutathione Peroxidase Levels and the Plasminogen Activator Inhibitor-1: Plasminogen Activator Inhibitor-2 Ratio in Pregnant Women
Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population
Plasma Levels of Plasminogen Activator Inhibitor Type 1 and Vitronectin in Children With Cancer
Effects of hormone replacement therapy on plasma and tissue fibrinolytic activity in a rat model of surgically induced menopause
Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: The effect of treatment with an angiotensin II receptor blocker
Comparison of Eff ects of Gliclazide, Metformin and Pioglitazone Monotherapies on Glycemic Control and Cardiovascular Risk Factors in Patients with Newly Diagnosed Uncontrolled Type 2 Diabetes Mellitus
Pleural effusion and plasma levels of fibrinolytic parameters in tuberculosis pleurisy and contribution to the diagnosis
Effect of heart rate control on coagulation status in patients of rheumatic mitral stenosis with atrial fibrillation-A pilot study
Coagulation factors, fibrinogen and plasminogen activator inhibitor-1, are differentially regulated by yellow fever virus infection of hepatocytes
Sputum Plasminogen Activator Inhibitor-1 Elevation by Oxidative Stress-Dependent Nuclear Factor-kappaB Activation in COPDPlasminogen Activator Inhibitor-1 Elevation in COPD
Haemostatic factors and intraluminal thrombus thickness in abdominal aortic aneurysm. Is secondary fibrinolysis relevant?
Effect of a Congolese herbal medicine used in sickle cell anemia on the expression of plasminogen activators in human coronary aortic endothelial cells culture
Association of Left Ventricular Longitudinal Strain with Mortality among Stable Hemodialysis Patients with Preserved Left Ventricular Ejection Fraction
Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma
Trauma-Induced Coagulopathy: Standard Coagulation Tests, Biomarkers of Coagulopathy, and Endothelial Damage in Patients with Traumatic Brain Injury
Circadian Rhythms in the Efficacy of Intravenous Alteplase in Patients With Acute Ischemic Stroke and Middle Cerebral Artery Occlusion
High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study
High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality
PLASMATIC SIL 6R/IL-6 RATIO AS A POTENTIAL PREDICTOR OF HIGH GLEASON SUM AT RADICAL PROSTATECTOMY
Thrombelastography and biomarker profiles in acute coagulopathy of trauma: A prospective study
Antiangiogenic Activity of rPAI-123 Promotes Vasa Vasorum Regression in Hypercholesterolemic Mice Through a Plasmin-Dependent Mechanism
Haemostatic effects of simvastatin in subjects with impaired glucose tolerance
Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study
Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors
Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects
Effects of Polyphenolic Compounds on Tumor Necrosis Factor-alpha (TNF-alpha)-Induced Changes of Adipokines and Oxidative Stress in 3T3-L1 Adipocytes
Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke
Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity
GnRH receptor and peritoneal plasmin activity
Nafamostat Mesilate (FUT-175) Inhibits Cell Growth and Invasion of Malignant Pleural Mesothelioma Cell Line, MSTO-211H
Treatment related changes in antifibrinolytic activity in patients with polycythemia vera
Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract
Activation of human mast cells through the platelet-activating factor receptor
Urokinase-type plasminogen activator system and human cationic antimicrobial protein 18 in serum and induced sputum of patients with chronic obstructive pulmonary disease
Nuts, inflammation and insulin resistance
Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus
Hypertension and hemostatic/fibrinolytic balance disorders
Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
INHIBITOR OF PAI-1 PRODUCTION
A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study
Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle
The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma
Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells
Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients
Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease
Is Familial Mediterranean Fever a thrombotic disease or not?
In vitro regulation of adipogenesis: tunable engineered tissues
Synergistic effects of pravastatin and pioglitazone in renal tubular epithelial cells induced by transforming growth factor-beta1
Glucose-Based PD Solution, But Not Icodextrin-Based PD Solution, Induces Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator in Human Peritoneal Mesothelial Cells via ERK1/2
Interleukin-1beta enhances the angiotensin-induced expression of plasminogen activator inhibitor-1 through angiotensin receptor upregulation in human astrocytes
Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells
Plasminogen and plasmin activity in patients with coronary artery disease
Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis
Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion
Hypoxia enhances the expression of plasmino activator inhibitors-1 in human lung cancer cells, EBC-1
Evaluation of thrombomodulin/thrombin activatable fibrinolysis inhibitor function in plasma using tissue-type plasminogen activator-induced plasma clot lysis time
- https://pubmed.ncbi.nlm.nih.gov/39026660/
- Tetsumei Urano, Yoshie Sano, ..., Yuko Suzuki (2024). Research and Practice in Thrombosis and Ha…. 2024 May 28
- Plasma concentrations of total TAFI, activated TAFI and its inactive derivative (TAFIa/ai), sTM, and plasminogen activator inhibitor 1 (PAI-1) were assayed using the following commercially available enzyme-linked immunosorbent assay (ELISA) kits: total TAFI: IMUCLONE Total TAFI ELISA (BioMedica Diagnostics Inc); TAFIa/ai: ASSERACHROM TAFIa/TAFIai (Diagnostica Stago); sTM (kit): Quantikine ELISA Human Thrombomodulin/BDCA-3 (R&D Systems); and PAI-1: Human PAI-1 ELISA Kit (catalog number EP1100-1, Assaypro).
Exposure to incense burning, biomarkers, and the physical health of temple workers in Taiwan.
- https://pubmed.ncbi.nlm.nih.gov/37659022/
- Su-Er Guo, Pamela A Ratner, ..., Ying-Chun Yu (2023). Environmental science and pollution resear…. 2023 Oct 02
- .. ELISA kit using a Human C-Reactive Protein ELISA Kit (Assaypro, St Charles, MO, USA).. ELISA was performed to determine PAI-1 concentrations using the Human PAI-1 Assay Max ELISA Kit (Assaypro, St Charles, MO, USA).. 8-OHdG levels were measured using an 8-OHdG ELISA Kit (Finetest, Wuhan, Hubei, China).8-OHdG levels ..
Plasminogen Activator Inhibitor 1 (PAI-1) and Haematologic Parameters in HIV- Positive Patients on Protease Inhibitor-Based HAART Regimen: A Case-Control Study
- https://pubmed.ncbi.nlm.nih.gov/36411985/
- ChimeziemChimeziem Christopher Christopher, Benedict Nwogoh (2022). Clinical and Applied Thrombosis/Hemostasis. 2022 Nov 21
- This was done in the main haematology laboratory, UCTH.. Plasminogen activator inhibitor 1 Assay: Assaypro enzyme-linked immunoassay kit was used for the estimation of PAI-1 levels.. CD4 count estimation: CD4 count was estimated with a FACS machine.
Cadmium induces plasminogen activator inhibitor-1 via Smad2/3 signaling pathway in human endothelial EA.hy926 cells.
- https://pubmed.ncbi.nlm.nih.gov/33952801/
- Takato Hara, Miki Sakuma, ..., Chika Yamamoto (2021). The Journal of toxicological sciences. 2021 Sep 06
- .. USA).Fibrinogen and thrombin from human plasma were purchased from Sigma-Aldrich (St. Louis, MO, USA).. Enzyme-linked immunosorbent assay (ELISA) kits for human t-PA and PAI-1 were purchased from Assaypro LLC (St. Charles, MO, USA).. ISOGEN-II, GeneAce SYBR qPCR mix α, and negative control siRNA were purchased from Nippon ..
Post-traumatic Stress Disorder: A Biopsychosocial Case-control Study Investigating Peripheral Blood Protein Biomarkers
- No Link Provided
- Daniel Maguire, Joanne Watt, ..., Mark W. Ruddock (2021). Biomarkers in Neuropsychiatry. 2021 Sep 01
- .. Switzerland).Folic acid and vitamin B12 were analysed on a Cobas Analyser (Roche, Basel, Switzerland).. Human tissue-type plasminogen activator (tPA) and human type-1 plasminogen activator inhibitor (PAI1/tPA) complex ELISAs were obtained from AssayPro (St. Charles, Missouri, USA).. Midkine ELISAs were obtained from CellMid, (Sydney, Australia).Midkine ELISAs were obtained from CellMid, (Sydney, ..
Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina
- https://pubmed.ncbi.nlm.nih.gov/34258054/
- Sunil Kumar, Amit Kumar Verma, ..., Renu Saxena (2021). Cardiology Research and Practice. 2021 Jun 25
- 2.3. PAI-1 Antigen AssayPAI-1 antigen was measured by a quantitative sandwich enzyme immunoassay technique (Assaypro LLC, St. Charles, USA) with a working range from 5 to 40 ng/ml. ELISA was performed strictly according to the manufacturer's instructions provided in the kit manual.
Regular Resistance Training Enhances Fibrinolytic Potential but Does Not Affect Coagulation
- https://pubmed.ncbi.nlm.nih.gov/34115732/
- PAUL R. NAGELKIRK, KAYLA SOAVE, ..., ANDREW DEL POZZI (2021). Medicine & Science in Sports & Exercise. 2021 Jun 11
- In the study, Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit from Assaypro was used to quantify plasma concentrations of total PAI-1 antigen, which is essential for u…
Drospirenone Effects on the Plasminogen Activator System in Immortalized Human Endometrial Endothelial Cells
- https://pubmed.ncbi.nlm.nih.gov/33559058/
- Reem Sabouni, David F. Archer (2021). Reproductive Sciences. 2021 Feb 08
- Abstract: Drospirenone (DRSP) is a fourth-generation progestin that interacts with the progesterone receptor (PR) and androgen receptor (AR) in addition to uniquely interacting to the mineralocorticoi…
Arsenite Inhibits Tissue-Type Plasminogen Activator Synthesis through NRF2 Activation in Cultured Human Vascular Endothelial EA.hy926 Cells
- https://pubmed.ncbi.nlm.nih.gov/33451022/
- TsuyoshiTsuyoshi Nakano Nakano, TsutomuTsutomu Takahashi Takahashi, ToshiyukiToshiyuki Kaji Kaji (2021). International Journal of Molecular Science…. 2021 Jan 13
- Measurement of t-PA, PAI-1, and PGI2 Secretion The conditioned medium of endothelial EA.hy926 cells treated with 1, 2, 5, or 10 µM arsenite for 24 h at 37 °C in a 24-well culture plate was used to measure t-PA and PAI-1 secretion with an enzyme-linked immunosorbent assay kit (AssayPro LLC, St. Charles, MO, USA), after which the cell layer was analyzed for DNA content using a fluorometric method [ ] to normalize the t-PA and PAI-1 content in the conditioned medium per µg DNA.
Nobiletin represses change in the levels of blood coagulation markers in the LPS-induced rat DIC model
- No Link Provided
- Kimihiko Takada, Mayuko Takano, ..., Yutaka Masuda (2020). Functional Foods in Health and Disease. 2020 Sep 25
- .. the addition of 0.1 mL of 0.02 M calcium chloride was measured with KC-4A.. PAI-1 antigen levels were measured by sandwich ELISA using Assay Max® PAI-1 ELISA Kit (Assay Pro, MO).. FDP concentrations were measured by a latex agglutination FDLP test (Kyowa Medex, Tokyo, Japan).FDP ..
Alu-repeat polymorphism in the tissue plasminogen activator (t-PA) gene, seminal t-PA concentration, and male fertility impairment: A case-control study
- https://pubmed.ncbi.nlm.nih.gov/32930675/
- Lubna Hamid Tahtamouni, Mahmoud Nael Hamdan, Majdoleen Sobhi Rammaha (2020). International Journal of Reproductive Biom…. 2020 Aug 19
- .. microplate reader (Synergy HTX Multi-Mode Reader, USA) at a 450 nm was read immediately.. On the other hand, seminal PAI-1/t-PA concentration was measured using the Human PAI-1/t-PA ELISA Kit (Assaypro LLC, USA).. The activity of seminal t-PA was assayed using the Human t-PA Chromogenic Activity Kit ..
Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease
- https://pubmed.ncbi.nlm.nih.gov/32821285/
- Sylwia Wasiak, Dean Gilham, ..., Ewelina Kulikowski (2020). Cardiovascular therapeutics. 2020 Aug 01
- 2.4. ELISATo assess the APR protein secretion, culture media from primary human hepatocyte cultures were collected over the final 24 h of treatment, flash-frozen in liquid nitrogen, and stored at -80°C prior to analysis. Secreted proteins were detected with AssayMax™ ELISA Kits (AssayPro).
Hemostatic Adaptations to High Intensity Interval Training in Healthy Adult Men
- https://pubmed.ncbi.nlm.nih.gov/32634847/
- James R. Sackett, Dan P. Farrell (2020). International journal of sports medicine. 2020 Jul 07
- Abstract: Regular exercise is theorized to reduce cardiovascular risk by attenuating coagulation and augmenting fibrinolysis. However, these adaptations have not been consistently observed during trad…
Relationship among HbA1c and Some Markers of Endothelial Damage in Type 2 Diabetes Mellitus
- No Link Provided
- Ifeanyichukwu Martin Ositadinma, Ngwu Amauche Martina, Eluke Blessing Chekwube (2019). International Blood Research Reviews. 2019 May 11
- Plasma plasminogen activator inhibitor-1 antigen and von Willebrand factor antigen were measured by AssayMax™ ELISA Kits from Assaypro (3400 Harry S Truman Blvd St.Charles, MO 63301 USA). Glycated hemoglobin was determined by glycohaemoglobin reagent set from Teco diagnostic (Lakeview Avenue Anaheim, California, U.S.A).
Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute‐on‐chronic liver failure: An observational cohort study
- https://pubmed.ncbi.nlm.nih.gov/30589495/
- Madhumita Premkumar, Priyanka Saxena (2019). Liver International. 2019 Feb 07
- Abstract: Patients with acute-on-chronic liver failure (ACLF) have coagulation failure in the setting of systemic inflammatory syndrome (SIRS), sepsis and extra-hepatic organ failures. Consecutive ACL…
Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study
- https://pubmed.ncbi.nlm.nih.gov/30701381/
- Felix Carl Fabian Schmitt, Vasil Manolov, ..., Thorsten Brenner (2019). Annals of Intensive Care. 2019 Jan 30
- Plasma levels of thrombin–antithrombin complex (TAT), plasminogen activator inhibitor 1 (PAI-1), free tissue plasminogen activator (tPA) and total tissue plasminogen activator (total tPA) were measured using enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer’s instructions (Assaypro, St. Charles, USA).. ELISA measurements were performed in duplicate.ELISA measurements were performed in ..
Homocysteine-Enhanced Proteolytic and Fibrinolytic Processes in Thin Intraluminal Thrombus and Adjacent Wall of Abdominal Aortic Aneurysm: Study In Vitro
- https://pubmed.ncbi.nlm.nih.gov/30643799/
- Aldona Siennicka, Marta Zuchowski, ..., Maria Jastrzębska (2018). BioMed Research International. 2018 Dec 12
- A) were used to measure haemostatic parameters in aortic tissue homogenates. A microplate reader (EnVision Multilabel Plate Reader; PerkinElmer, USA) and manufacturer's instructions of kits (all from AssayPro, St. Charles, Missouri, USA) were followed to determine: Tissue factor activity (AssaySense Human Tissue Factor (TF) Chromogenic Activity Assay Kit); tissue plasminogen activator (t-PA) concen
Tissue factor levels and the fibrinolytic system in thin and thick intraluminal thrombus and underlying walls of abdominal aortic aneurysms
- https://pubmed.ncbi.nlm.nih.gov/29571624/
- Aldona Siennicka, Marta Zuchowski (2018). Journal of vascular surgery. 2018 Dec 01
- .. homogenates, as follows: TF activity: AssaySense Human TF Chromogenic Activity Assay Kit (AssayPro, St. Charles, Mo); plasmin activity: SensoLyte AFC Plasmin Activity Assay Kit (AnaSpec, Fremont, Calif); tPA concentrations: AssayMax Human tPA ELISA kit (AssayPro); plasminogen concentrations: AssayMax Human Plasminogen ELISA kit (AssayPro); PAI-1 concentrations: AssayMax Human PAI-1 ELISA Kit (AssayPro); a2AP concentrations: Human Alpha-2Antiplasmin, Alpha-2-AP ELISA Kit (Wuhan EIAab Science Co, Ltd, Wuhan, China).
Can biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies?
- https://pubmed.ncbi.nlm.nih.gov/28823228/
- Shereef Elmoamly, Alaa Afif (2017). Hematology. 2017 Aug 20
- ted samples were discarded. Commercial ELISA methods were used to measure plasma levels of D-dimer (Technozym®, Technoclone, Vienna, Austria), PAI-1, VWF antigen, TNF-a, and IL-6 (all from AssayMax®, AssayPro, St. Charles, MO, U.S.A.), human fibrinogen (GenWay, San Diego, CA, U.S.A.), human pselectin (RayBio, Norcross, GA, U.S.A.). The ELISA biomarkers were performed according to the manufacturer’s
Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries.
- https://pubmed.ncbi.nlm.nih.gov/27425379/
- Erkan Elci, Cihan Kaya, ..., Gulhan Gunes Elci (2017). Gynecological endocrinology : the official…. 2017 Jun 05
- In the study, the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit from Assaypro was utilized to measure serum PAI-1 levels, which was essential for comparing cardiac r…
Dysfunctional fibrinolysis and cerebral venous thrombosis
- https://pubmed.ncbi.nlm.nih.gov/28552473/
- Aniket Prabhudesai, Shrimati Shetty (2017). Blood cells, molecules & diseases. 2017 Jun 01
- Abstract: Cerebral venous thrombosis (CVT) is an uncommon neurological disease with high morbidity and mortality. Even after extensive thrombophilia screening, majority of the thrombosis cases remain …
Establishment of disseminated intravascular coagulation (DIC) model by a single iv administration of Escherichia coli-derived lipopolysaccharide (LPS) to cynomolgus monkeys and evaluation of its pathophysiological status.
- https://pubmed.ncbi.nlm.nih.gov/28215474/
- Hirofumi Minomo, Kengo Inoue, ..., Atsuro Miyata (2017). Journal of pharmacological sciences. 2017 May 04
- .. NEO, Sysmex Corporation, Hyogo, Japan), Plasmin-a2-plasmin inhibitor complex (PIC, RIAS AUTO PIC, Sysmex Corporation, Hyogo, Japan), Soluble fibrin monomer (SF, IATRO SF II, LSI Medience Corporation, Tokyo, Japan) and Plasminogen activator inhibitor 1 (PAI-1, AssayMax Human Plasminogen Activator Inhibitor (PAI-1) ELISA Kit, Assaypro LLC., MO, USA) and serum: TNF-a (NHP TNF-a Simplex, Affymetrix, CA, disseminated intravascular coagulation (DIC) model by a single iv nomolgus monkeys and evaluation of its pathophysiological status, hs.2017.01.005 USA), ..
Frailty has a stronger association with inflammation than age in older veterans
- https://pubmed.ncbi.nlm.nih.gov/28239399/
- P. Van Epps, D. Oswald, ..., D. H. Canaday (2016). Immunity & ageing : I & A. 2016 Oct 19
- .. index is a calculated parameter: 0.333*log (IL-6) + 0.666*log (sTNFR1).. The following markers of thrombosis and coagulation were also measured: Plasminogen activator inhibitor-1 (PAI-1) (AssayMax Human PAI-1 ELISA kit, Assaypro, St. Charles, MO, USA), D-dimer (ELISA ZYMUTEST DDimer, ANIARA, West Chester, OH, USA) and Fibrinogen (immunoperoxidase assay, GenWay, San Diego, CA, USA).
Plasma Levels of Plasminogen Activator Inhibitor Type 1 and Vitronectin in Children With Cancer.
- https://pubmed.ncbi.nlm.nih.gov/24770328/
- D Tugcu, O Devecioglu, ..., G Aydogan (2016). Clinical and applied thrombosis/hemostasis…. 2016 Sep 21
- In this study, the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit was pivotal in measuring the plasma levels of PAI-1 among pediatric cancer patients, allowing for a …
Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD)
- https://pubmed.ncbi.nlm.nih.gov/27496089/
- Cathrin Sellmann, Cheng Jun Jin (2016). European journal of nutrition. 2016 Aug 05
- Abstract: Impairments of intestinal barrier function are discussed as risk factors for the development and progression of non-alcoholic fatty liver disease (NAFLD). Studies suggest an association betw…
Comparison of the effects of intensive insulin treatment modalities on cardiovascular biomarkers in type 1 diabetes mellitus.
- https://pubmed.ncbi.nlm.nih.gov/25952036/
- Sevki Cetinkalp, Canan Felekoglu, ..., Candeger Yilmaz (2016). Diabetes & metabolic syndrome. 2016 May 05
- In the study, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was utilized to measure PAI-1 levels in serum samples. This data was crucial for corr…
A microfluidic cell culture system for monitoring of sequential changes in endothelial cells after heat stress.
- https://pubmed.ncbi.nlm.nih.gov/26044666/
- Hidekatsu Tazawa, Kenjiro Sato, ..., Ritsuko Ohtani-Kaneko (2016). Thrombosis research. 2016 May 03
- .. centrifuged for 10 min at 3000 × g at 4 °C to remove debris.. Supernatants were subjected to a PAI-1 assay using Human PAI-1 ELISA Kit (ASSAYPRO; St. Charles, MO, USA).. The estimation of PAI-1 concentration was performed according to the manufacturer’s protocol.The estimation of ..
Tranexamic Acid Compared with Placebo for Reducing Total Blood Loss in Hip Replacement Surgery
- https://pubmed.ncbi.nlm.nih.gov/26991616/
- Borja Barrachina, Amanda Lopez-Picado, ..., Roberto Hernanz (2016). Anesthesia & Analgesia. 2016 Apr 01
- Abstract: 986 www.anesthesia-analgesia.org April 2016 • Volume 122 • Number 4 Copyright © 2016 International Anesthesia Research Society DOI: 10.1213/ANE.0000000000001159 With increases in life expect…
Coagulation, Fibrinolysis and Inhibitors in Failing Filters during Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: Effect of Anticoagulation Modalities.
- https://pubmed.ncbi.nlm.nih.gov/25966765/
- Louise Schilder, S Azam Nurmohamed, ..., A B Johan Groeneveld (2016). Blood purification. 2016 Mar 24
- In the study, the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit from Assaypro was utilized to measure PAI-1 levels in blood samples from patients receiving continuou…
Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy
- https://pubmed.ncbi.nlm.nih.gov/27630384/
- S. O. Ajibola, T. A. Adeyemo, A. S. Akanmu (2016). Nigerian Medical Journal : Journal of the …. 2016 Jan 01
- In addition, 4.5 ml (9 volumes) of venous blood was collected by venepuncture into vacuum tubes containing 0.5 ml (1 volume) of 0.129 M trisodium citrate and the plasma was separated after 2500 g centrifugation for 10 min and stored at − 40°C till analyzed for maternal plasma FN and PAI-1 levels by enzyme-linked immunosorbent assay (ELISA) (AssayMax PAI-1 and FN ELISA kit manufactured by Assaypro laboratory company, St. Charles, USA).
Effect of heart rate control on coagulation status in patients of rheumatic mitral stenosis with atrial fibrillation – A pilot study ☆
- https://pubmed.ncbi.nlm.nih.gov/26688152/
- Jamal Yusuf, Mayank Goyal, ..., Vijay Trehan (2015). Indian Heart Journal. 2015 Dec 16
- cerebio, China; normal human plasma values are 31.2–2000 pmol/ml; intra- and inter-assay coefficient of variation of < 8% and < 10%, respectively) and plasma TAT (enzyme linked immunosorbent assay; Assaypro, USA; normal human plasma values are 0.5–10 ng/ml; intra- and inter-assay coefficients of variation were < 5% and < 8%) concentrations as markers of in vivo thrombin generation were measured
Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study
- https://pubmed.ncbi.nlm.nih.gov/25907781/
- Sisse Rye Ostrowski, Nicolai Haase, ..., Pär Ingemar Johansson (2015). Critical Care. 2015 Apr 24
- .. (LLD) 4.94 ng/ml) and soluble thrombomodulin (sTM, Nordic Biosite, Copenhagen, Denmark; LLD 0.31 ng/ml), both in serum; protein C (PC, Helena Laboratories, Beaumont, TX, US; relative quantification); tissue-type plasminogen activator (tPA, Americal Diagnostics (ADI), detects single-chain (sc)-tissue type plasminogen activator (tPA), two-chain (tc)-tPA and tPA/PAI-1 complexes; LLD 1 ng/ml) and plasminogen activator inhibitor-1 (PAI-1, Assaypro; LLD 0.07 ng/ml), all in citrated plasma.
Effects of Selenium Supplementation on Soluble FMS-Like Tyrosine Kinase-1 and Glutathione Peroxidase Levels and the Plasminogen Activator Inhibitor-1: Plasminogen Activator Inhibitor-2 Ratio in Pregnant Women
- No Link Provided
- Mina Mousavi, Elahe Heidari, ..., Gordon Ferns (2015). Shiraz E-Medical Journal. 2015 Mar 31
- Plasminogen activator inhibitor-1 was measured by the ELISA kit (Assay Max Human Plasminogen Activator Inhibitor-1 (PAI-1) from Assay Pro Company, USA).. The minimum detectable concentration of PAI-1 was 200 pg/ mL and the inter- and ..
Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus.
- https://pubmed.ncbi.nlm.nih.gov/24710641/
- C Erem, H M Ozbas, ..., H O Ersoz (2014). Experimental and clinical endocrinology & …. 2014 Dec 30
- In the study evaluating glycemic control and cardiovascular risk factors in patients with type 2 diabetes, the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit from Ass…
Pleural Effusion and Plasma Levels of Fibrinolytic Parameters in Tuberculosis Pleurisy and Contribution to the Diagnosis
- No Link Provided
- Burcu Akkok, Sibel Yurt, ..., Filiz Kosar (2014). Eurasian Journal of Pulmonology. 2014 Sep 02
- Plasma and pleural fluid D-Dimer (HYPHEN Biomed, D-Dimer, Catalogue Number: RK023A), fibrinogen (Assaypro, USA, Catalogue No. EF1040-1), t-PA/PAI-1 complex (Assaypro, USA, Catalogue No. EP1105-1), PAI-1 (Assaypro, USA, Catalogue No.EP1100-1) and tPA (Assaypro, USA, Catalogue No. ET1001-1) were studied using commercial kits based on the principle of competitive ELISA.
Association of left ventricular longitudinal strain with mortality among stable hemodialysis patients with preserved left ventricular ejection fraction.
- https://pubmed.ncbi.nlm.nih.gov/23704303/
- Yen-Wen Liu, Chi-Ting Su, ..., Wei-Chuan Tsai (2014). Clinical Journal of the American Society o…. 2014 May 07
- Sera were stored at 280°C until analysis and then thawed to measure the levels of cardiac troponin T (cTnT) (fourth-generation Troponin T STAT immunoassay, ElecSys 2010 System; Roche Diagnostics, Indianapolis, IN), high-sensitivity C-reactive protein (BN II analyzer; Dade Behring, Glasgow, DE), IL-6 (chemiluminescent sandwich ELISA, Quantikine Human IL-6; R&D Systems Inc., Minneapolis, MN), and plasminogen-activator inhibitor type 1 (PAI-1) (Human PAI-1 ELISA Kit; Assaypro, St. Charles, MO).
Effects of Hormone Replacement Therapy on Plasma and Tissue Fibrinolytic Activity in a Rat Model of Surgically Induced Menopause
- https://pubmed.ncbi.nlm.nih.gov/24690423/
- Ata Topcuoglu, Mustafa Albayrak, ..., Hafize Uzun (2014). Clinical Investigative Medicine. 2014 Apr 01
- the various analytes were assayed using the supernatant fraction. Assay of tPA, PAI-1 and tPA/PAI-1 levels tPA, PAI-1, and tPA/PAI-1 levels in plasma and tissues (brain and liver) were measured using Assaypro ELISA kits according to the manufacturer’s instructions (AssayMax ELISA kit; Assaypro, Win eld, MO, USA). Estradiol in serum was measured using the Chemiluminescent Microparticle Immunoassay (
Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: The effect of treatment with an angiotensin II receptor blocker
- https://pubmed.ncbi.nlm.nih.gov/24621621/
- E Gavriilaki, E Gkaliagkousi, ..., S Douma (2014). Journal of human hypertension. 2014 Mar 13
- Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was instrumental in measuring PAI-1 levels in patients with essential hypertension, providing critical …
Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population
- https://pubmed.ncbi.nlm.nih.gov/25350781/
- Yang Sun (2014). Medical Science Monitor. 2014 Jan 01
- .. was isolated with standard phenol-chloroform method.The genomic DNA was isolated with standard phenol-chloroform method.. Plasma level of PAI-1 was measured by use of an AssayMax Human Plasminogen Activator Inhibitor-1 ELISA kit (AssayPro, St. Charles, MO, USA).. PAI-1 (-675) 4G/5G polymorphism and -844G/A polymorphisms were determined using a standard polymerase chain ..
Coagulation factors, fibrinogen and plasminogen activator inhibitor-1, are differentially regulated by yellow fever virus infection of hepatocytes
- https://pubmed.ncbi.nlm.nih.gov/23639427/
- Sara E. Woodson, Alexander N. Freiberg (2013). Virus research. 2013 Aug 01
- Abstract: Yellow fever virus (YFV) infection poses a great risk to un-vaccinated individuals living or traveling in the endemic regions of Africa and South America. It is estimated that approximately …
Circadian rhythms in the efficacy of intravenous alteplase in patients with acute ischemic stroke and middle cerebral artery occlusion.
- https://pubmed.ncbi.nlm.nih.gov/23130962/
- Dolores Vilas, Meritxell Gomis, ..., Antoni Dávalos (2013). Chronobiology international. 2013 Jul 24
- In this study, the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit from Assaypro was critical in determining PAI-1 levels in patients with acute ischemic stroke. This …
Trauma-Induced Coagulopathy: Standard Coagulation Tests, Biomarkers of Coagulopathy, and Endothelial Damage in Patients with Traumatic Brain Injury
- https://pubmed.ncbi.nlm.nih.gov/23134525/
- Gustav Folmer Genét, Pär Ingemar Johansson (2013). Journal of neurotrauma. 2013 Feb 15
- Abstract: It remains to be debated whether traumatic brain injury (TBI) induces a different coagulopathy than does non-TBI. This study investigated traditional coagulation tests, biomarkers of coagulo…
Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma
- https://pubmed.ncbi.nlm.nih.gov/23960372/
- Pär I Johansson, Nis A Windeløv, ..., Sisse R Ostrowski (2013). Journal of Emergencies, Trauma, and Shock. 2013 Jan 01
- .. Biosite, Copenhagen, Denmark); D-dimer (ADI) and soluble CD40 ligand (sCD40L, RandD Systems Europe). ... Citrate plasma: Protein C (PC, Helena Laboratories, Beaumont, TX, US); activated protein C (APC, USCNLIFE, Ltd. Wuhan, China); tissue-type plasminogen activator (tPA, ADI); plasminogen activator inhibitor-1 (PAI-1, Assaypro, Sct.. Charles, MO, US); prothrombinfragment 1 and 2 (PF1.2, USCNLIFE); thrombin/antithrombin complex (TAT, USCNLIFE); tissue ..
Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy.
- https://pubmed.ncbi.nlm.nih.gov/22743373/
- Sisse R Ostrowski, Pär I Johansson (2012). The journal of trauma and acute care surge…. 2012 Sep 17
- In the study, the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit from Assaypro was utilized to measure plasminogen activator inhibitor 1 levels in plasma samples from…
Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets, and leukocytes in response to increasing injury severity.
- https://pubmed.ncbi.nlm.nih.gov/22610188/
- Pär I Johansson, Anne Marie Sørensen, ..., Sisse R Ostrowski (2012). Critical Care Medicine. 2012 Jul 13
- Abstract: High patient age is a strong predictor of poor outcome in trauma patients. The present study investigated the effect of age on mortality and biomarkers of sympathoadrenal activation, tissue,…
High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality.
- https://pubmed.ncbi.nlm.nih.gov/22151659/
- P I Johansson, A M Sørensen, ..., S R Ostrowski (2012). Journal of thrombosis and haemostasis : JT…. 2012 Jun 11
- Citrate plasma: protein C (PC, Helena Laboratories, Beaumont, TX, USA; LLD 5% of reference plasma); activated protein C (APC, USCNLIFE; LLD 4.2 pg mL)1); soluble endothelial protein C receptor (sEPCR; R&D Systems Europe; LLD 0.064 ng mL)1); protein S (PS, ADI; LLD not stated, quantified relative to provided reference plasma); tissue-type plasminogen activator (tPA, ADI, detects sc-tPA, tc-tPA and tPA/PAI-1 complexes; LLD 1 ng mL)1); plasminogen activator inhibitor-1 (PAI-1, Assaypro, Sct.
High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study
- https://pubmed.ncbi.nlm.nih.gov/22490186/
- Sisse R Ostrowski, Anne Marie Sørensen, ..., Pär I Johansson (2012). Scandinavian Journal of Trauma, Resuscitat…. 2012 Jan 01
- .. activated protein C (APC, USCNLIFE; LLD 4.2 pg/ml); soluble endothelial protein C receptor (sEPCR, R&D Systems Europe; LLD 0.064 ng/ml); tissue-type plasminogen activator (tPA, ADI, detects sc-tPA, tc-tPA and tPA/PAI-1 complexes; LLD 1 ng/ml); plasminogen activator inhibitor-1 (PAI-1, Assaypro; LLD 0.2 ng/ml); prothrombinfragment 1 and 2 (PF1.2, USCNLIFE; LLD 0.043 nmol/l); von Willebrand Factor antigen (vWF, Helena Laboratories, LLD 5% of reference plasma); interleukin-6 (IL-6, Quantikine HS, R&D Systems Europe; LLD 0.039 pg/ml). ..
Cross-sectional association of nut intake with adiposity in a Mediterranean population
- https://pubmed.ncbi.nlm.nih.gov/20219336/
- P. Casas-Agustench, M. Bulló (2011). Nutrition, Metabolism and Cardiovascular D…. 2011 Jul 01
- Abstract: Nut intake has been inversely related to body mass index (BMI) in prospective studies. We examined dietary determinants of adiposity in an elderly Mediterranean population with customarily h…
Antiangiogenic Activity of rPAI-123 Promotes Vasa Vasorum Regression in Hypercholesterolemic Mice Through a Plasmin-Dependent Mechanism
- https://pubmed.ncbi.nlm.nih.gov/21546607/
- Jessica Mollmark, Saranya Ravi, ..., Mary Jo Mulligan-Kehoe (2011). Circulation research. 2011 Jun 10
- PAI-1 activity was measured in plasma protein (600 μ g) by 2 methods. One method measured activity by ELISA (AssayPro, St Charles, MO) and the other in a chromozym assay (American Diagnostica). The experiment was performed on plasma collected into sodium citrate tubes from 5 mice per treatment group and analyzed according to the manufacturers’ protocol. Each assay was repeated twice in triplicate
Haemostatic effects of simvastatin in subjects with impaired glucose tolerance
- https://pubmed.ncbi.nlm.nih.gov/21118403/
- R. Krysiak, B. Okopien (2011). Internal medicine journal. 2011 Jun 01
- In the study evaluating the effects of simvastatin on coagulation in patients with impaired glucose tolerance, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit pl…
Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome.
- https://pubmed.ncbi.nlm.nih.gov/20031380/
- P Casas-Agustench, P López-Uriarte, ..., J Salas-Salvadó (2011). Nutrition, metabolism, and cardiovascular …. 2011 May 19
- In the study, the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit from Assaypro was utilized to measure plasminogen activator inhibitor-1 levels in serum samples. This…
Treatment related changes in antifibrinolytic activity in patients with polycythemia vera.
- https://pubmed.ncbi.nlm.nih.gov/21114901/
- Mehmet Sonmez, Fatma Saglam, ..., Ercument Ovali (2011). Hematology (Amsterdam, Netherlands). 2011 Mar 08
- In the study on treatment-related changes in antifibrinolytic activity in patients with polycythemia vera, the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit from Ass…
Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors
- https://pubmed.ncbi.nlm.nih.gov/29684380/
- Elisabetta Cenni, Caterina Fotia, Nicola Baldini (2011). Acta Orthopaedica. 2011 Feb 10
- Plasminogen Plasminogen was determined with a chromogenic assay (HemosIL Plasminogen, Instrumentation Laboratory).. Plasminogen activator inhibitor-1 PAI-1 was detected in citrated plasma by enzyme immunoassay (AssayMax Human Plasminogen Activator Inhibitor-1 (PAI-1) ELISA Kit; Assaypro, St. Charles, MO).. Plasminogen activator inhibitor-1 PAI-1 was detected in citrated plasma by enzyme immunoassay (AssayMax Human ..
Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study
- https://pubmed.ncbi.nlm.nih.gov/42616029/
- Pär I Johansson, Anne Marie Sørensen, ..., Sisse R Ostrowski (2011). Critical Care. 2011 Jan 01
- .. Abingdon, UK; LLD 0.064 ng/ml); protein S (PS, ADI; LLD not stated, quantified relative to provided reference plasma); tissue-type plasminogen activator (tPA, ADI, detects sc-tPA, tc-tPA and tPA/plasminogen activator inhibitor (PAI)-1 complexes; LLD 1 ng/ml); plasminogen activator inhibitor-1 (PAI-1, Assaypro, St. Charles, MO, USA; LLD 0.2 ng/ml); prothrombinfragment 1 and 2 (PF1.2, USCNLIFE; LLD 0.043 nmol/l); thrombin/antithrombin complex (TAT, USCNLIFE, Wuhan EIAab Science Co, Wuhan, China; LLD 0.215 ng/ml); tissue factor pathway inhibitor (TFPI, ADI, ..
Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study
- https://pubmed.ncbi.nlm.nih.gov/22029598/
- Sisse R Ostrowski, Anne Marie Sørensen, ..., Pär I Johansson (2011). Scandinavian Journal of Trauma, Resuscitat…. 2011 Jan 01
- .. C (PC, Helena Laboratories, Beaumont, TX, US; LLD 5% of reference plasma); activated protein C (APC, USCNLIFE; LLD 4.2 pg/ml); tissue-type plasminogen activator (tPA, ADI, detects sc-tPA, tc-tPA and tPA/PAI-1 complexes; LLD 1 ng/ml); plasminogen activator inhibitor-1 (PAI-1, Assaypro; LLD 0.2 ng/ml); prothrombinfragment 1 and 2 (PF1.2, USCNLIFE; LLD 0.043 nmol/l); plasmin/α 2 -antiplasmin complex (PAP, ADI; LLD not stated); thrombin/antithrombin complex (TAT, USCNLIFE; LLD 0.215 ng/ml); tissue factor pathway inhibitor (TFPI, ADI, ..
Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects
- https://pubmed.ncbi.nlm.nih.gov/21663566/
- Abayomi O. Akanji, Abdulwahab N. Al-Isa, Lukman Thalib (2011). Clinical chemistry and laboratory medicine. 2011 Jan 01
- The study utilized the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro to effectively quantify PAI-1 plasma levels among healthy Arab adolescents. This…
Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke
- https://pubmed.ncbi.nlm.nih.gov/24571954/
- Antonino Tuttolomondo, Domenico Di Raimondo, ..., Giuseppe Licata (2010). Atherosclerosis. 2010 Nov 01
- In this study, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was instrumental in measuring PAI-1 levels in acute ischemic stroke patients. This a…
Urokinase-type plasminogen activator system and human cationic antimicrobial protein 18 in serum and induced sputum of patients with chronic obstructive pulmonary disease
- https://pubmed.ncbi.nlm.nih.gov/20624254/
- Yuanyuan JIANG, Wei XIAO, ..., Ying XING (2010). Respirology. 2010 Jul 06
- In this study, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was essential for measuring PAI-1 levels in both serum and induced sputum from COPD …
Activation of human mast cells through the platelet-activating factor receptor
- https://pubmed.ncbi.nlm.nih.gov/20392487/
- Naoki Kajiwara, Tomomi Sasaki, ..., Yoshimichi Okayama (2010). Journal of Allergy and Clinical Immunology. 2010 May 01
- In the study, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was employed to measure PAF concentrations in plasma samples from human subjects foll…
Ezetimibe Therapy and Its Influence on Oxidative Stress and Fibrinolytic Activity
- https://pubmed.ncbi.nlm.nih.gov/20375933/
- Nurver Turfaner, Hafize Uzun, ..., Habibe Genc (2010). Southern Medical Journal. 2010 May 01
- The study employed the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit to assess PAI-1 levels in hyperlipidemic patients undergoing ezetimibe treatment. This measure…
Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract.
- https://pubmed.ncbi.nlm.nih.gov/19640694/
- Dhungana Sandra, Madhyastha Radha, ..., Maruyama Masugi (2010). Phytomedicine : international journal of p…. 2010 Mar 30
- In this study, the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit from Assaypro played a significant role in quantifying PAI-1 levels, which were essential for assess…
GnRH receptor and peritoneal plasmin activity
- https://pubmed.ncbi.nlm.nih.gov/20236028/
- Noriko Suzuki, Akio Yamamoto, ..., Atsushi Imai (2010). Gynecological Endocrinology. 2010 Mar 18
- In this study, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was instrumental in measuring PAI-1 levels in human peritoneal Met5A cells exposed t…
Prostaglandin E2 Acts via Multiple Receptors to Regulate Plasminogen-Dependent Proteolysis in the Primate Periovulatory Follicle
- https://pubmed.ncbi.nlm.nih.gov/18818294/
- Nune Markosyan, Diane M. Duffy (2010). pmc02630891. 2010 Jan 01
- After 3 h incubation, proteolytic zones were visible distant from the tissue section, indicating spontaneous degradation of milk casein. tPA and PAI-1 measurements in follicular fluid Follicular fluid levels of total tPA and total PAI-1 were determined using AssayMax Human tPA and AssayMax Human PAI-1 ELISA kits (AssayPro, St. Charles, MO) according to the kit instructions.
Hypertension and hemostatic/fibrinolytic balance disorders
- https://pubmed.ncbi.nlm.nih.gov/20003834/
- O Tabak, R Gelisgen, ..., Y Karter (2009). Clinical Investigative Medicine. 2009 Dec 01
- same batch). Plasma PAI–1, tPA, tPA/PAI–1 complex levels were measured by a quantitative sandwich enzyme immunoassay technique, using commercial assay kits, according to manufacturer’s instructions (Assaypro, Brooklyn, USA). Absorbance values were read in an ELISA plate reader and the concentration of samples was automatically calculated by software. Samples were run in duplicate, and the 2 measur
Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus.
- https://pubmed.ncbi.nlm.nih.gov/19037607/
- Tim K Tso, Wen-Nan Huang (2009). Rheumatology international. 2009 Sep 02
- In the study examining cardiovascular disease risk in female patients with systemic lupus erythematosus (SLE), the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit was …
Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
- https://pubmed.ncbi.nlm.nih.gov/19253106/
- Baha Oral, Betül Mermi, ..., Recep Sütçü (2009). Gynecological endocrinology : the official…. 2009 Jun 19
- In this study investigating hemostatic parameters in women with polycystic ovary syndrome (PCOS), the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit from Assaypro pla…
mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3.
- https://pubmed.ncbi.nlm.nih.gov/19331815/
- Susann Busch, Stephen J Renaud, ..., Udo R Markert (2009). Experimental cell research. 2009 May 26
- In the study analyzing mTOR's role in trophoblast invasion, the Human PAI 1 tPA AssayMax ELISA Kit from Assaypro was employed to measure PAI-1 levels in cell-conditioned media. This qu…
A suppressive effect of prostaglandin E 2 on the expression of SERPINE1 /plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study.
- https://pubmed.ncbi.nlm.nih.gov/27789978/
- Kayo Masuko, Minako Murata, ..., Tomohiro Kato (2009). Open Access Rheumatology : Research and Re…. 2009 Apr 17
- .. using ImageJ software (http://rsb.info.nih.gov/ij/).Densitometry of the signal bands was analyzed using ImageJ software (http://rsb.info.nih.gov/ij/).. Enzyme-linked immunosorbent assay (ELISA) The level of PAI-1 in the culture supernatant was measured by using an ELISA kit (AssayMax Human Plasminogen activator inhibitor-1 ELISA KitTM, AssayPro LLC, St. Charles, MO, USA).. According to the manufacturer, the minimum detectable concentration of PAI-1 by the kit was ..
A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study
- https://pubmed.ncbi.nlm.nih.gov/27789978/
- Kayo Masuko, Minako Murata, Tomohiro Kato (2009). Open Access Rheumatology : Research and Re…. 2009 Jan 01
- Densitometry of the signal bands was analyzed using ImageJ software ( http://rsb.info.nih.gov/ij/ ).. Enzyme-linked immunosorbent assay (ELISA) The level of PAI-1 in the culture supernatant was measured by using an ELISA kit (AssayMax Human Plasminogen activator inhibitor-1 ELISA Kit™, AssayPro LLC, St. Charles, MO, USA).. According to the manufacturer, the minimum detectable concentration of PAI-1 by the kit was ..
A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study
- https://pubmed.ncbi.nlm.nih.gov/27789978/
- Kayo Masuko, Minako Murata, Tomohiro Kato (2009). Open Access Rheumatology : Research and Re…. 2009 Jan 01
- Densitometry of the signal bands was analyzed using ImageJ software ( http://rsb.info.nih.gov/ij/ ).. Enzyme-linked immunosorbent assay (ELISA) The level of PAI-1 in the culture supernatant was measured by using an ELISA kit (AssayMax Human Plasminogen activator inhibitor-1 ELISA Kit™, AssayPro LLC, St. Charles, MO, USA).. According to the manufacturer, the minimum detectable concentration of PAI-1 by the kit was ..
A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study
- https://pubmed.ncbi.nlm.nih.gov/27789978/
- Kayo Masuko, Minako Murata, Tomohiro Kato (2009). Open Access Rheumatology : Research and Re…. 2009 Jan 01
- Densitometry of the signal bands was analyzed using ImageJ software ( http://rsb.info.nih.gov/ij/ ).. Enzyme-linked immunosorbent assay (ELISA) The level of PAI-1 in the culture supernatant was measured by using an ELISA kit (AssayMax Human Plasminogen activator inhibitor-1 ELISA Kit™, AssayPro LLC, St. Charles, MO, USA).. According to the manufacturer, the minimum detectable concentration of PAI-1 by the kit was ..
Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells
- https://pubmed.ncbi.nlm.nih.gov/19088796/
- Katarzyna Oszajca, Magdalena Bieniasz, ..., Janusz Szemraj (2008). Biochemistry and Cell Biology. 2008 Dec 01
- In this study, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was instrumental in measuring PAI-1 levels in human umbilical vein endothelial cells…
The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.
- https://pubmed.ncbi.nlm.nih.gov/18058801/
- Hiromi Sato, Hiromi Hagiwara, ..., Tomohiro Yano (2008). Molecular carcinogenesis. 2008 Aug 19
- In the study investigating the inhibitory effect of connexin 32 on metastasis in renal cell carcinoma, the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit from Assaypr…
Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients*
- https://pubmed.ncbi.nlm.nih.gov/18434900/
- Lies Langouche, Wouter Meersseman, ..., Greet Van den Berghe (2008). Critical Care Medicine. 2008 May 01
- In the study investigating the effects of insulin therapy on critically ill patients, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was instrumen…
Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells
- https://pubmed.ncbi.nlm.nih.gov/17581316/
- Chikamasa Yoshida, Kenji Niiya (2007). Blood Coagulation Fibrinolysis. 2007 Jul 01
- .. a plasminogen-containing fibrin plate (fibrin zymography) as previously described [24].. IL-8 and plasminogen activator inhibitor type-1 (PAI-1) antigen levels in the cultured medium were measured using a quantitative enzymelinked immunosorbent assay (ELISA) kit for IL-8 (Immunotech, Marseille, France) and a human PAI-1 ELISA kit (Assaypro, St Charles, Missouri, USA), respectively.. A specific MAPK kinase (MEK) 1/2 inhibitor U0126, purchased from ..
Synergistic effects of pravastatin and pioglitazone in renal tubular epithelial cells induced by transforming growth factor-β1
- https://pubmed.ncbi.nlm.nih.gov/17208021/
- J WEI, C MA, ..., Y LI (2007). Cell biology international. 2007 May 01
- In this study, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro played a significant role in measuring PAI-1 levels in human renal proximal tubular …
Is Familial Mediterranean Fever a thrombotic disease or not?
- https://pubmed.ncbi.nlm.nih.gov/17436016/
- Atalay Demirel, Tiraje Celkan, ..., Inci Yıldız (2007). European journal of pediatrics. 2007 Apr 14
- In the study on Familial Mediterranean Fever (FMF), the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was pivotal in measuring PAI-1 levels, which we…
Glucose-Based PD Solution, But Not Icodextrin-Based PD Solution, Induces Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator in Human Peritoneal Mesothelial Cells via ERK1/2
- https://pubmed.ncbi.nlm.nih.gov/17381529/
- Masahira Katsutani, Takafumi Ito, ..., Noriaki Yorioka (2007). Therapeutic Apheresis and Dialysis. 2007 Apr 01
- In this study, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was essential for quantifying PAI-1 levels in human peritoneal mesothelial cells exp…
In vitro regulation of adipogenesis: tunable engineered tissues
- https://pubmed.ncbi.nlm.nih.gov/18038403/
- Chih-Chao Yang, Steve E. Ellis, ..., Karen J. L. Burg (2007). Journal of tissue engineering and regenera…. 2007 Jan 01
- In this study, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit was essential for quantifying PAI-1 levels in the conditioned medium of mammary epithelial cells, …
Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells
- https://pubmed.ncbi.nlm.nih.gov/16856978/
- G. A. ROTH, B. MOSER, ..., E. LALLA (2006). Journal of Thrombosis and Haemostasis. 2006 Oct 01
- In the study investigating the impact of Porphyromonas gingivalis on endothelial cell properties, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro p…
Plasminogen and plasmin activity in patients with coronary artery disease
- https://pubmed.ncbi.nlm.nih.gov/16706973/
- M. C. DRINANE, J. A. SHERMAN, ..., M. J. MULLIGAN-KEHOE (2006). Journal of Thrombosis and Haemostasis. 2006 Jun 01
- es. PAI-1 levels in samples from all blots were calculated based on the densitometry of the known concentration of the purified PAI-1 control. PAI-1 levels were analyzed by ELISA (AssayMax ELISA kit; Assaypro, Winfield, MO, USA) according to the manufacturer’s directions. Each plate contained a PAI-1 standard curve ranging from 0.078–1.25 ng mL)1. Measurements were made on triplicate samples. Stand
Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
- https://pubmed.ncbi.nlm.nih.gov/16289236/
- Hiromi Hagiwara, Hiromi Sato, ..., Tomohiro Yano (2006). Life Sciences. 2006 May 16
- In the study on metastatic renal cell carcinoma, the Human Plasminogen Activator Inhibitor 1 PAI 1 AssayMax ELISA Kit was instrumental in measuring PAI-1 levels within Caki-1 cells. Th…
Interleukin-1β enhances the angiotensin-induced expression of plasminogen activator inhibitor-1 through angiotensin receptor upregulation in human astrocytes
- https://pubmed.ncbi.nlm.nih.gov/16427616/
- Hidemi Yoshida, Tadaatsu Imaizumi, ..., Kei Satoh (2006). Brain research. 2006 Feb 01
- In the study, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was instrumental in measuring PAI-1 levels in human astrocytes under the influence of…
Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion
- https://pubmed.ncbi.nlm.nih.gov/14644129/
- Natsuo Oka, Yuushi Okumura, ..., Susumu Kagawa (2003). European Urology. 2003 Dec 01
- In the study, the Human Plasminogen Activator Inhibitor-1 (PAI-1) AssayMax ELISA Kit from Assaypro was utilized to measure the levels of uPA and plasmin in urothelial cancer cell lines…